These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils. Zhang M; Angata T; Cho JY; Miller M; Broide DH; Varki A Blood; 2007 May; 109(10):4280-7. PubMed ID: 17272508 [TBL] [Abstract][Full Text] [Related]
6. Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling. Song DJ; Cho JY; Lee SY; Miller M; Rosenthal P; Soroosh P; Croft M; Zhang M; Varki A; Broide DH J Immunol; 2009 Oct; 183(8):5333-41. PubMed ID: 19783675 [TBL] [Abstract][Full Text] [Related]
8. Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13. Cho JY; Song DJ; Pham A; Rosenthal P; Miller M; Dayan S; Doherty TA; Varki A; Broide DH Respir Res; 2010 Nov; 11(1):154. PubMed ID: 21040544 [TBL] [Abstract][Full Text] [Related]
10. Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis. Rubinstein E; Cho JY; Rosenthal P; Chao J; Miller M; Pham A; Aceves SS; Varki A; Broide DH J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):409-16. PubMed ID: 21970996 [TBL] [Abstract][Full Text] [Related]
11. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors. Bochner BS Clin Exp Allergy; 2009 Mar; 39(3):317-24. PubMed ID: 19178537 [TBL] [Abstract][Full Text] [Related]
12. Galactose 6-O-sulfotransferases are not required for the generation of Siglec-F ligands in leukocytes or lung tissue. Patnode ML; Cheng CW; Chou CC; Singer MS; Elin MS; Uchimura K; Crocker PR; Khoo KH; Rosen SD J Biol Chem; 2013 Sep; 288(37):26533-45. PubMed ID: 23880769 [TBL] [Abstract][Full Text] [Related]
13. Frontline Science: Superior mouse eosinophil depletion in vivo targeting transgenic Siglec-8 instead of endogenous Siglec-F: Mechanisms and pitfalls. Knuplez E; Krier-Burris R; Cao Y; Marsche G; O'Sullivan J; Bochner BS J Leukoc Biol; 2020 Jul; 108(1):43-58. PubMed ID: 32134149 [TBL] [Abstract][Full Text] [Related]
14. Characterization of expression of glycan ligands for Siglec-F in normal mouse lungs. Guo JP; Brummet ME; Myers AC; Na HJ; Rowland E; Schnaar RL; Zheng T; Zhu Z; Bochner BS Am J Respir Cell Mol Biol; 2011 Feb; 44(2):238-43. PubMed ID: 20395633 [TBL] [Abstract][Full Text] [Related]
15. Siglec-F Promotes IL-33-Induced Cytokine Release from Bone Marrow-Derived Eosinophils Independently of the ITIM and ITIM-like Motif Phosphorylation. Westermann S; Dietschmann A; Doehler D; Castiglione K; Bochner BS; Voehringer D; Radtke D J Immunol; 2022 Feb; 208(3):732-744. PubMed ID: 34996839 [TBL] [Abstract][Full Text] [Related]
16. Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse model. Song DJ; Cho JY; Miller M; Strangman W; Zhang M; Varki A; Broide DH Clin Immunol; 2009 Apr; 131(1):157-69. PubMed ID: 19135419 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygen. Mao H; Kano G; Hudson SA; Brummet M; Zimmermann N; Zhu Z; Bochner BS PLoS One; 2013; 8(6):e68143. PubMed ID: 23840825 [TBL] [Abstract][Full Text] [Related]
18. The role of lung epithelial ligands for Siglec-8 and Siglec-F in eosinophilic inflammation. Kiwamoto T; Katoh T; Tiemeyer M; Bochner BS Curr Opin Allergy Clin Immunol; 2013 Feb; 13(1):106-11. PubMed ID: 23160308 [TBL] [Abstract][Full Text] [Related]
19. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand. Tateno H; Crocker PR; Paulson JC Glycobiology; 2005 Nov; 15(11):1125-35. PubMed ID: 15972893 [TBL] [Abstract][Full Text] [Related]
20. Non-invasive optical imaging of eosinophilia during the course of an experimental allergic airways disease model and in response to therapy. Markus MA; Dullin C; Mitkovski M; Prieschl-Grassauer E; Epstein MM; Alves F PLoS One; 2014; 9(2):e90017. PubMed ID: 24587190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]